Coumadin and Fulvestrant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coumadin and Fulvestrant. Common interactions include dizziness among females.

The phase IV clinical study analyzes what interactions people who take Coumadin and Fulvestrant have. It is created by eHealthMe based on reports of 14 people who take Coumadin and Fulvestrant from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 03, 2022

14 people who take Coumadin and Fulvestrant together, and have interactions are studied.


What is Coumadin?

Coumadin has active ingredients of warfarin sodium. It is often used in blood clots. eHealthMe is studying from 131,496 Coumadin users for its effectiveness, alternative drugs and more.

What is Fulvestrant?

Fulvestrant has active ingredients of fulvestrant. eHealthMe is studying from 9,832 Fulvestrant users for its effectiveness, alternative drugs and more.

Number of Coumadin and Fulvestrant reports submitted per year:

Coumadin and Fulvestrant drug interactions.

Common Coumadin and Fulvestrant drug interactions by gender *:

female:

  1. Dizziness
  2. General physical health deterioration
  3. Hypertension
  4. Impaired healing
  5. Musculoskeletal discomfort
  6. Osteomyelitis
  7. Osteonecrosis of jaw
  8. Pain
  9. Sinus disorder
  10. Spinal osteoarthritis

male:

n/a

Common Coumadin and Fulvestrant drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dizziness
  2. General physical health deterioration
  3. Headache
  4. Migraine
  5. Nausea
  6. Subarachnoid haemorrhage
  7. Vasculitis
  8. Vomiting

40-49:

n/a

50-59:

  1. Aortic calcification
  2. Aortic valve incompetence
  3. Arthralgia
  4. Atelectasis
  5. Axillary mass
  6. Back pain
  7. Blood pressure increased
  8. Bone lesion
  9. Bone pain
  10. Cardiac failure congestive

60+:

  1. Death
  2. Pneumonia
  3. White blood cell count decreased

Common conditions people have *:

  1. Breast Cancer Female: 2 people, 14.29%
  2. Breast Cancer: 2 people, 14.29%
  3. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 1 person, 7.14%
  4. Rectal Cancer (cancer of rectum): 1 person, 7.14%
  5. Muscle Spasms (muscle contraction): 1 person, 7.14%
  6. Metastases To Liver (cancer spreads to liver): 1 person, 7.14%
  7. High Blood Pressure: 1 person, 7.14%
  8. Colon Cancer: 1 person, 7.14%
  9. Breast Cancer Stage Iv: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Coumadin and Fulvestrant?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Coumadin and Fulvestrant interactions:

Browse all drug interactions of Coumadin and Fulvestrant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Coumadin interactions:

Browse all interactions between Coumadin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fulvestrant interactions:

Browse all interactions between Fulvestrant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium and fulvestrant (the active ingredients of Coumadin and Fulvestrant, respectively), and Coumadin and Fulvestrant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Coumadin and Fulvestrant.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: